| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2092130 | RPL30 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 8 | - |
PV=0.751 FDR=1 FC=-0.002 |
|
| 2092131 | CCNJ | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 10 | - |
PV=1 FDR=1 FC=0.056 |
|
| 2092132 | CCNJ | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 10 | - |
PV=1 FDR=1 FC=-0.266 |
|
| 2092133 | IFNAR2 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 21 | - |
PV=1 FDR=1 FC=-0.145 |
